FI852405L - Substituerade 3,4-diamino-1,2,5 -tiadiazoler med antagoniserande inverkan pao histaminets h2-receptorer. - Google Patents

Substituerade 3,4-diamino-1,2,5 -tiadiazoler med antagoniserande inverkan pao histaminets h2-receptorer.

Info

Publication number
FI852405L
FI852405L FI852405A FI852405A FI852405L FI 852405 L FI852405 L FI 852405L FI 852405 A FI852405 A FI 852405A FI 852405 A FI852405 A FI 852405A FI 852405 L FI852405 L FI 852405L
Authority
FI
Finland
Prior art keywords
thiadiazoler
receptorer
histaminets
antagoniserande
inverkan
Prior art date
Application number
FI852405A
Other languages
English (en)
Finnish (fi)
Other versions
FI852405A0 (fi
Inventor
Aldo A Algieri
Ronnie R Crenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI852405A0 publication Critical patent/FI852405A0/fi
Publication of FI852405L publication Critical patent/FI852405L/fi
Priority to FI894344A priority Critical patent/FI894344A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI852405A 1984-06-22 1985-06-17 Substituerade 3,4-diamino-1,2,5 -tiadiazoler med antagoniserande inverkan pao histaminets h2-receptorer. FI852405L (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI894344A FI894344A0 (fi) 1984-06-22 1989-09-14 Foerfarande foer framstaellning av etandi-imidamider.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (2)

Publication Number Publication Date
FI852405A0 FI852405A0 (fi) 1985-06-17
FI852405L true FI852405L (fi) 1985-12-23

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852405A FI852405L (fi) 1984-06-22 1985-06-17 Substituerade 3,4-diamino-1,2,5 -tiadiazoler med antagoniserande inverkan pao histaminets h2-receptorer.

Country Status (33)

Country Link
US (1) US4644006A (da)
JP (2) JPS6118775A (da)
KR (1) KR900004321B1 (da)
AR (1) AR240935A1 (da)
AT (1) AT390790B (da)
AU (2) AU580605B2 (da)
BE (1) BE902724A (da)
CA (2) CA1267412A (da)
CH (1) CH665210A5 (da)
CS (1) CS257276B2 (da)
DD (1) DD240889A5 (da)
DE (1) DE3522101A1 (da)
DK (1) DK282885A (da)
ES (2) ES8702902A1 (da)
FI (1) FI852405L (da)
FR (1) FR2566406B1 (da)
GB (2) GB2161157B (da)
GR (1) GR851514B (da)
HU (1) HU193992B (da)
IE (2) IE58261B1 (da)
IL (1) IL75567A0 (da)
IT (1) IT1190372B (da)
LU (1) LU85969A1 (da)
NL (1) NL8501766A (da)
NO (1) NO161856C (da)
NZ (1) NZ212403A (da)
OA (1) OA08039A (da)
PT (1) PT80684B (da)
SE (1) SE464305B (da)
SU (1) SU1537136A3 (da)
YU (2) YU45725B (da)
ZA (1) ZA854710B (da)
ZW (1) ZW10385A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
EP0045155B1 (en) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FR2542741B1 (fr) * 1982-03-29 1989-12-08 Bristol Myers Co 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
SE464305B (sv) 1991-04-08
AU2977589A (en) 1989-06-01
NO852519L (no) 1985-12-23
IE58261B1 (en) 1993-08-25
ES8702902A1 (es) 1987-01-16
AR240935A1 (es) 1991-03-27
HU193992B (en) 1987-12-28
YU102587A (en) 1988-02-29
LU85969A1 (fr) 1986-01-24
GB8515749D0 (en) 1985-07-24
DD240889A5 (de) 1986-11-19
GB2192884A (en) 1988-01-27
US4644006A (en) 1987-02-17
KR900004321B1 (ko) 1990-06-22
FI852405A0 (fi) 1985-06-17
ES8702881A1 (es) 1987-01-16
ES551506A0 (es) 1987-01-16
CH665210A5 (de) 1988-04-29
IE851557L (en) 1985-12-22
SU1537136A3 (ru) 1990-01-15
HUT42087A (en) 1987-06-29
PT80684A (en) 1985-07-01
IE57937B1 (en) 1993-05-19
AU580605B2 (en) 1989-01-19
YU105185A (en) 1987-12-31
YU45822B (sh) 1992-07-20
NO161856B (no) 1989-06-26
DK282885A (da) 1985-12-23
PT80684B (en) 1987-05-08
IT1190372B (it) 1988-02-16
CA1267412A (en) 1990-04-03
AT390790B (de) 1990-06-25
SE8503110L (sv) 1985-12-23
IT8521217A0 (it) 1985-06-20
ZA854710B (en) 1986-02-26
SE8503110D0 (sv) 1985-06-20
FR2566406B1 (fr) 1988-01-29
BE902724A (fr) 1985-12-23
ZW10385A1 (en) 1986-02-05
ATA185885A (de) 1989-12-15
DK282885D0 (da) 1985-06-21
NZ212403A (en) 1989-04-26
DE3522101A1 (de) 1986-01-02
JPS61186369A (ja) 1986-08-20
CS424785A2 (en) 1987-09-17
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
KR860000275A (ko) 1986-01-27
GB2192884B (en) 1988-08-10
AR240935A2 (es) 1991-03-27
GR851514B (da) 1985-11-25
IL75567A0 (en) 1985-10-31
AU614331B2 (en) 1991-08-29
CA1297875C (en) 1992-03-24
GB2161157A (en) 1986-01-08
GB2161157B (en) 1988-08-10
ES544409A0 (es) 1987-01-16
GB8716149D0 (en) 1987-08-12
FR2566406A1 (fr) 1985-12-27
AU4392085A (en) 1986-01-02
JPS6118775A (ja) 1986-01-27
OA08039A (fr) 1987-01-31
CS257276B2 (en) 1988-04-15
YU45725B (sh) 1992-07-20

Similar Documents

Publication Publication Date Title
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
MX21592A (es) 1,3-oxazolidin-2-ona.
FI860033A0 (fi) Anordning foer faestande av platta isolermaterial, i synnerhet vaermeisoleringsmattor eller -papp, pao tunnvaeggiga underlag, saosom plaoten i ventilationskanaler.
IT8521944A0 (it) 1,4-diidropiridine-2-sostituite.
FI842455A0 (fi) Foerbindning foer roer med kragad aende.
FI852202L (fi) Foer bildandet av med teknetium maerkt, foer radiodiagnostiska aemnen tillaempat loesligt kopparsalt innehaollande kompositioner.
FI852899A0 (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
FI853686L (fi) Foerfarande foer framstaellning av 2,4 -diklor-5-fluorbensoesyra.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI850197L (fi) Foerfarande foer kontroll av byggdelar med hjaelp av en virvelstroem, i synnerhet i kaerntekniska anlaeggningar.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI853421A0 (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI863300A (fi) 7-oxo-4-tia-1-azabicyclo/3,2,0/ hept-2-enderivat.
FI861950A0 (fi) 1,3-dioxan-etrar.
FI855182A0 (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI852405A0 (fi) Substituerade 3,4-diamino-1,2,5 -tiadiazoler med antagoniserande inverkan pao histaminets h2-receptorer.
FI865158A0 (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
FI853287A0 (fi) Nytt foerfarande foer framstaellning av 6-substituerad-furo-(3,4-c)-pyridinderivat.
FI853585L (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
FI854026A0 (fi) 2-fenylpyrano/2,3-b/pyridiner.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
FI852372L (fi) Foerfarande foer framstaellning av substituerade 1,3-dioxanderivat.
ATE58134T1 (de) 1,3-dioxanaether.
ATE51400T1 (de) 3,4-dihydrobenzopyranderivate.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY